N-(3-cyanophenyl)-7-(pyridin-4-yl)-2,3-dihydrobenzo[f][1,4]oxazepine-4(5H)-carboxamide

ID: ALA4763234

PubChem CID: 162660699

Max Phase: Preclinical

Molecular Formula: C22H18N4O2

Molecular Weight: 370.41

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N#Cc1cccc(NC(=O)N2CCOc3ccc(-c4ccncc4)cc3C2)c1

Standard InChI:  InChI=1S/C22H18N4O2/c23-14-16-2-1-3-20(12-16)25-22(27)26-10-11-28-21-5-4-18(13-19(21)15-26)17-6-8-24-9-7-17/h1-9,12-13H,10-11,15H2,(H,25,27)

Standard InChI Key:  ZMKWHQJUHAUIFS-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   29.2771  -15.7495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2760  -16.5690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9840  -16.9780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9823  -15.3406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5699  -16.9773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8622  -16.5665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1546  -16.9738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1536  -17.7919    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.8659  -18.2009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5706  -17.7912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6957  -16.5661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6909  -15.7459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3319  -15.2249    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.3457  -17.0757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1363  -15.3976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1487  -16.8845    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.4977  -16.1369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6650  -17.5179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3746  -18.2818    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.4717  -17.3875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.9880  -18.0209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6949  -18.7833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2105  -19.4164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0181  -19.2862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3076  -18.5175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7901  -17.8877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1129  -18.3826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9192  -18.2494    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3 11  2  0
 12  4  2  0
  4  1  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  2  5  1  0
 11 12  1  0
 12 13  1  0
 11 14  1  0
 13 15  1  0
 14 16  1  0
 15 17  1  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 27 28  3  0
 25 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4763234

    ---

Associated Targets(Human)

GPR142 Tchem Probable G-protein coupled receptor 142 (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Gpr142 Probable G-protein coupled receptor 142 (77 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 370.41Molecular Weight (Monoisotopic): 370.1430AlogP: 4.05#Rotatable Bonds: 2
Polar Surface Area: 78.25Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.02CX Basic pKa: 5.16CX LogP: 3.01CX LogD: 3.00
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.74Np Likeness Score: -1.91

References

1. Wilson JE,Kurukulasuriya R,Sinz C,Lombardo M,Bender K,Parker D,Sherer EC,Costa M,Dingley K,Li X,Mitelman S,Tong S,Bugianesi R,Ehrhardt A,Priest B,Ratliff K,Ujjainwalla F,Nargund R,Hagmann WK,Edmondson S.  (2016)  Discovery and development of benzo-[1,2,4]-triazolo-[1,4]-oxazepine GPR142 agonists for the treatment of diabetes.,  26  (12.0): [PMID:27240550] [10.1016/j.bmcl.2016.04.018]

Source